M K Brenner

The contribution of marker gene studies to hemopoietic stem cell therapies

M. Brenner, M K Brenner, 1995, Stem cells.

Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the treatment of patients with EBV-positive relapsed Hodgkin's disease.

S Kimbrough, H. Heslop, C. Rooney, 1998, Blood.

Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients.

D. Srivastava, R. Krance, H. Heslop, 1998, Blood.

Use of gene marking in bone marrow transplantation.

R. Krance, H. Heslop, C. Rooney, 1996, Cancer detection and prevention.

Donor T cells to treat EBV-associated lymphoma.

H. Heslop, C. Rooney, M. Brenner, 1994, The New England journal of medicine.